中文名：Avelumab (anti-PD-L1)
英文名：Avelumab (anti-PD-L1)
中文別名：阿維單抗; 阿維魯單抗; Recombinant Avelumab Antibody; Avelumab; Anti-Human PD-L1, Human Antibody; Anti-PD-L1; MSB0010718C; Bavencio; B7 H antibody; B7 H1 antibody; B7 homolog 1 antibody; B7-H1 antibody; B7H antibody; B7H1 antibody; CD 274 antibody; CD-274 antibody;
英文別名：Recombinant Avelumab Antibody; Avelumab; Anti-Human PD-L1, Human Antibody; Anti-PD-L1; MSB0010718C; Bavencio; B7 H antibody; B7 H1 antibody; B7 homolog 1 antibody; B7-H1 antibody; B7H antibody; B7H1 antibody; CD 274 antibody; CD-274 antibody; CD274 antibo
純度：Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
貨號：A412006
包裝：5mg、10mg、1mg
Cas號：1537032-82-8
存儲溫度：-80℃儲存,避免反復(fù)凍融
產(chǎn)品介紹：
velumab 是一種完全人IgG1單克隆抗體，靶向 protein programmed death-ligand 1 (PD-L1)。Avelumab 具有潛在的抗體依賴性細(xì)胞介導(dǎo)的細(xì)胞毒性作用，可用于多種癌癥的治療。
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對應(yīng)頁面：https://www.aladdin-e.com/zh_cn/A412006.html
關(guān)鍵字： 阿維單抗; 阿維魯單抗; Recombinant Avelumab Antibody; Avelumab; Anti-Human PD-L1, Human Antibody; Anti-PD-L1; MSB0010718C; Bavencio; B7 H antibody; B7 H1 antibody; B7 homolog 1 antibody; B7-H1 antibody; B7H antibody; B7H1 antibody; CD 274 antibody; CD-274 antibody;;Recombinant Avelumab Antibody; Avelumab; Anti-Human PD-L1, Human Antibody; Anti-PD-L1; MSB0010718C; Bavencio; B7 H antibody; B7 H1 antibody; B7 homolog 1 antibody; B7-H1 antibody; B7H antibody; B7H1 antibody; CD 274 antibody; CD-274 antibody; CD274 antibo
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代碼：688179），專注于科研試劑的研發(fā)、生產(chǎn)和銷售，已陸續(xù)建立多個(gè)工廠和研發(fā)中心。作為領(lǐng)軍企業(yè)，阿拉丁始終堅(jiān)持質(zhì)量第一，連續(xù)13年被評為“最受歡迎試劑品牌”。
阿拉丁目前常備庫存試劑產(chǎn)品品種超過7萬種，SKU總數(shù)超過46萬，產(chǎn)品線涵蓋了化學(xué)試劑、生化試劑、藥靶配體、蛋白質(zhì)和抗體等多個(gè)領(lǐng)域，是國內(nèi)少數(shù)化學(xué)試劑到生物試劑全面發(fā)展的國產(chǎn)試劑品牌，產(chǎn)品同步發(fā)布在我們國內(nèi)外電商平臺。